title: Pramipexole and gender identity disorder: expanding the phenotype of hypersexuality in Parkinson's disease.
authors.forename: Mahesh
authors.initials: M
authors.lastname: Odiyoor
authors.forename: Christopher
authors.initials: C
authors.lastname: Kobylecki
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Hackett
authors.forename: Monty A
authors.initials: MA
authors.lastname: Silverdale
authors.forename: Mark W
authors.initials: MW
authors.lastname: Kellett
mesh_terms: D000328:Adult; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D052160:Benzothiazoles / Q000009:adverse effects / Q000627:therapeutic use*; D005783:Gender Identity; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D010641:Phenotype; D000077487:Pramipexole; D020018:Sexual Dysfunctions, Psychological / Q000139:chemically induced* / Q000150:complications*
chemical_list: D000978:Antiparkinson Agents; D052160:Benzothiazoles; D000077487:Pramipexole